John Molina - Molina Healthcare CFO, Director
MOH Stock | USD 410.83 7.77 1.86% |
Director
Mr. John C. Molina J.D. is Director of the Company. He is Executive vice president, financial affairs, since 1995, treasurer since 2002, and chief financial officer since 2003. Past member of the Federal Reserve Bank of San Francisco board of directors, Los Angeles branch. Past president of the California Association of Primary Care Case Management Plans. Chairman of the board of directors of Aquarium of the Pacific. Juris Doctorate from the University of Southern California School of Law. since 2017.
Age | 51 |
Tenure | 7 years |
Address | 200 Oceangate, Long Beach, CA, United States, 90802 |
Phone | 562 435 3666 |
Web | https://www.molinahealthcare.com |
Molina Healthcare Management Efficiency
The company has Return on Asset of 0.0743 % which means that on every $100 spent on assets, it made $0.0743 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3039 %, implying that it generated $0.3039 on every 100 dollars invested. Molina Healthcare's management efficiency ratios could be used to measure how well Molina Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The Molina Healthcare's current Return On Capital Employed is estimated to increase to 0.43, while Return On Assets are projected to decrease to 0.07. As of now, Molina Healthcare's Other Current Assets are increasing as compared to previous years. The Molina Healthcare's current Non Current Assets Total is estimated to increase to about 2.5 B, while Intangible Assets are projected to decrease to under 120.3 M.Similar Executives
Showing other executives | DIRECTOR Age | ||
Yair Rabinowitch | Medigus Ltd ADR | 71 | |
Yair Rabinovitch | Medigus Ltd ADR | 67 | |
Wesley Schack | Edwards Lifesciences Corp | 74 | |
Yuval Yanai | Medigus Ltd ADR | 65 | |
Anat Naschitz | Medigus Ltd ADR | N/A | |
Barbara McNeil | Edwards Lifesciences Corp | 74 | |
Leslie Heisz | Edwards Lifesciences Corp | 60 | |
Martin Madden | Microbot Medical | 57 | |
Eitan Machover | Medigus Ltd ADR | 55 | |
Moshe Shoham | Microbot Medical | 64 | |
Martha Marsh | Edwards Lifesciences Corp | 72 | |
Erez Haimovitz | Medigus Ltd ADR | N/A | |
Nicholas Valeriani | Edwards Lifesciences Corp | 64 | |
Steven Loranger | Edwards Lifesciences Corp | 69 | |
Aviel Shapira | Medigus Ltd ADR | 61 | |
Jeremy Starkweather | Medigus Ltd ADR | 42 | |
Yoseph Bornstein | Microbot Medical | 65 | |
William Link | Edwards Lifesciences Corp | 73 | |
Solomon Mayer | Microbot Medical | 62 | |
Ori Hershkovitz | Medigus Ltd ADR | 39 | |
Prattipati Laxminarain | Microbot Medical | 59 |
Management Performance
Return On Equity | 0.3 | ||||
Return On Asset | 0.0743 |
Molina Healthcare Leadership Team
Elected by the shareholders, the Molina Healthcare's board of directors comprises two types of representatives: Molina Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molina. The board's role is to monitor Molina Healthcare's management team and ensure that shareholders' interests are well served. Molina Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molina Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph Molina, Chairman of the Board and Presidentident, CEO | ||
Steven James, Non-Executive Independent Director | ||
Joseph CFA, Senior Relations | ||
Jason Dees, Executive Vice President - Marketplace | ||
James Woys, Executive Vice President - Health Plan Services | ||
Maurice CPA, Chief Officer | ||
Charles Fedak, Independent Director | ||
Garrey Carruthers, Independent Director | ||
Brian Maddy, President - Oklahoma | ||
FAAFP DO, Executive Officer | ||
Joseph Zubretsky, President, Chief Executive Officer, Director | ||
David Reynolds, Senior Plans | ||
Terry Bayer, COO | ||
Juan Orellana, Investor Relations | ||
Esq JD, Chief Sec | ||
Pamela Sedmak, Executive Vice President - Health Plan Operations | ||
Thomas Tran, Chief Financial Officer, Treasurer | ||
John Kotal, Chief California | ||
Richard Zoretic, Independent Director | ||
Dale Wolf, Non-Executive Independent Director | ||
Maurice Hebert, Chief Accounting Officer | ||
Mark Keim, Executive Vice President - Executive Vice President Strategic Planning, Corporate Development & Transformation | ||
Jeffrey Barlow, Chief Legal Officer, Corporate Secretary | ||
Stephen Lockhart, Independent Director | ||
Barbara Brasier, Independent Director | ||
Richard Schapiro, Independent Director | ||
Jeff Barlow, Senior Vice President General Counsel, Secretary | ||
Joann ZarzaGarrido, Vice Compliance | ||
Dave Reynolds, Senior Vice President - Health Plans | ||
Keith Wilson, Chief Officer | ||
Daniel Cooperman, Non-Executive Independent Director | ||
Julie Trudell, Senior Vice President - Investor Relations | ||
Ronna Romney, Independent Vice Chairman of the Board | ||
Larry Anderson, Executive Officer | ||
David Pollack, VP Operations | ||
Frank Murray, Independent Director | ||
Marc Russo, Executive Vice President - Medicaid Health Plans | ||
Keith MD, Chief Officer | ||
Joseph White, Chief Accounting Officer | ||
John Molina, CFO, Director | ||
Steven Orlando, Independent Director |
Molina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Molina Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.3 | ||||
Return On Asset | 0.0743 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.04 % | ||||
Current Valuation | 17.79 B | ||||
Shares Outstanding | 58.58 M | ||||
Shares Owned By Insiders | 1.12 % | ||||
Shares Owned By Institutions | 98.88 % | ||||
Number Of Shares Shorted | 1.29 M | ||||
Price To Earning | 26.49 X |
Molina Healthcare Investors Sentiment
The influence of Molina Healthcare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Molina. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Molina Healthcare's public news can be used to forecast risks associated with an investment in Molina. The trend in average sentiment can be used to explain how an investor holding Molina can time the market purely based on public headlines and social activities around Molina Healthcare. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Molina Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Molina Healthcare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Molina Healthcare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Molina Healthcare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Molina Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Molina Healthcare's short interest history, or implied volatility extrapolated from Molina Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Molina Stock analysis
When running Molina Healthcare's price analysis, check to measure Molina Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molina Healthcare is operating at the current time. Most of Molina Healthcare's value examination focuses on studying past and present price action to predict the probability of Molina Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molina Healthcare's price. Additionally, you may evaluate how the addition of Molina Healthcare to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Molina Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molina Healthcare. If investors know Molina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.842 | Earnings Share 18.79 | Revenue Per Share 571.976 | Quarterly Revenue Growth 0.063 | Return On Assets 0.0743 |
The market value of Molina Healthcare is measured differently than its book value, which is the value of Molina that is recorded on the company's balance sheet. Investors also form their own opinion of Molina Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Molina Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molina Healthcare's market value can be influenced by many factors that don't directly affect Molina Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molina Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molina Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molina Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.